Vaccination coverage among children aged 13 to 59 months in Buenos Aires, Argentina, 2002

Gustavo H Dayan1, Liliana C Orellana, Raúl Forlenza

  • 1Epidemiology and Survaillance Division, Centers for Disease Control and Prevention, Atlanta, GA, USA. gdayan@cdc.gov

Insights

Complete childhood vaccination coverage in Buenos Aires remains low, despite high rates for individual vaccines. Key risk factors for incomplete vaccination include child's age, provider type, socioeconomic status, and caregiver education.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Vaccination is crucial for child health.
  • Understanding vaccination coverage and its determinants is vital for public health interventions.

Purpose of the Study:

  • To estimate antigen-specific and series-complete vaccination coverage in children aged 13-59 months in Buenos Aires.
  • To compare survey data with administrative records.
  • To identify risk factors for incomplete vaccination.

Main Methods:

  • A systematic community-based household survey was conducted in Buenos Aires in 2002.
  • Data were collected from 1391 children aged 13-59 months, requiring written vaccination documentation.
  • Risk factors were analyzed using univariate and multivariate logistic regression.

Main Results:

  • Antigen-specific coverage varied, with Haemophilus influenzae type b at 69.4% and BCG at 99%.
  • Survey coverage generally aligned with administrative records, except for measles.
  • Child's age, vaccination provider, socioeconomic factors (insurance, caregiver education), and geographic location were significant risk factors for incomplete vaccination.

Conclusions:

  • Complete vaccination coverage in Buenos Aires children is suboptimal.
  • Targeted interventions addressing identified risk factors are needed to improve vaccination rates.
Abstract

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...